Table 3 Medication in different groups.
| Â | FE | <10 yr | 10 to 20 yr | >20 yr | p |
|---|---|---|---|---|---|
Anticholinergic | 8% (8) | 13.1% (17) | 16.0% (17) | 31.5% (25) | 0.0002 |
Benzodiazepine | 36% (36) | 23.8% (31) | 44.4% (46) | 44.3% (35) | 0.0003 |
Antidepressant | 23% (23) | 42.3% (55) | 44.3% (47) | 43.0% (34) | 0.0043 |
Mood stabiliser | 9% (9) | 20.8% (27) | 30.2% (72) | 25.3% (20) | 0.0019 |
Antipsychotic | Â | Â | Â | Â | 0.0001 |
Only first generation | 3 %(3) | 4.6 %(6) | 9.5% (10) | 20.5% (16) | Â |
Only second generation | 94% (94) | 87.7% (113) | 74.5% (79) | 60.3% (47) | Â |
Combination | 3% (3) | 7.6% (10) | 16.0% (17) | 19.2% (15) | Â |
Second generation AP | 97% (97) | 94.6% (123) | 90.5% (96) | 78.5% (62) | Â |
Second generation (N = 400 prescriptions) | Â | Â | Â | Â | 0.0001 |
Amisulpride (n = 32) | 5% (5) | 5.8% (6) | 16.0% (17) | 5.9% (4) | Â |
Aripiprazole (n = 4) | 3% (3) | 0.7% (1) | 0% (0) | 0% (0) | Â |
Clozapine (n = 74) | 3% (3) | 15.5% (20) | 29.1% (30) | 30.9% (21) | Â |
Risperidone (n = 98) | 32% (32) | 20.2% (26) | 23.3% (24) | 23.5% (16) | Â |
Quetiapine (n = 53) | 10% (10) | 10.7% (25) | 10.7% (11) | 10.3% (7) | Â |
Olanzapine (n = 139) | 47% (47) | 31.1% (32) | 31.1% (32) | 29.4% (20) | Â |